Daiichi Sankyo, Inc. headquartered in Basking Ridge, New Jersey, is the U.S. subsidiary of Daiichi Sankyo, Co., Ltd. The Company is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs. We currently market therapies in hypertension, dyslipidemia, diabetes, acute coronary syndrome, thrombotic disorders, stroke risk reduction, opioid-induced constipation, IV iron therapy and metastatic melanoma. www.dsi.com.